Schobel Alexander Mark

CIK 00014068361 companyWARREN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001406836

Recent Transactions

50 trades

Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-15$6.00/sh−50,000→ 984,476 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-09$4.88/sh−5,895→ 1,034,476 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-09$4.88/sh−9,645→ 980,726 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-08$5.19/sh−25,000→ 1,040,371 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2024-03-07+41,250→ 41,250 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2024-03-07+82,500→ 1,065,371 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2023-08-09+50,000→ 50,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Performance Stock Units
2023-05-05+50,000→ 50,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Common Stock
2023-03-09+100,000→ 982,871 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2022-11-04+40,000→ 40,000 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Common Stock
2022-06-08$0.96/sh+45,871→ 882,871 total
Purchase
Aquestive Therapeutics, Inc.$AQST
Warrant (Right to Buy)
2022-06-08$0.13/sh+45,871→ 45,871 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2022-03-10+75,000→ 75,000 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2021-03-11+70,000→ 70,000 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-02-10$6.75/sh−23,460→ 837,000 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-02-09$6.75/sh−11,540→ 860,460 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2021-02-08$6.50/sh−40,792→ 872,000 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-06-30$4.86/sh−94→ 912,792 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2020-06-30−333→ 0 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-06-30+333→ 912,886 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-05-31+14,572→ 916,685 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-05-31$4.87/sh−4,132→ 912,553 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2020-05-31−14,572→ 0 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-05-08$5.00/sh−40,000→ 902,113 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-04-29$4.50/sh−40,000→ 1,022,113 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-04-27$4.00/sh−40,000→ 942,113 total
Sale
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-04-14$3.70/sh−40,000→ 982,113 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2020-03-31−329→ 333 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-03-31+329→ 1,062,210 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-03-31$2.19/sh−97→ 1,062,113 total
Award
Aquestive Therapeutics, Inc.$AQST
Non-Qualified Stock Option (right to buy)
2020-03-16+70,000→ 70,000 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-02-29+14,572→ 1,066,947 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2020-02-29−14,572→ 14,572 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2020-02-29$3.73/sh−5,066→ 1,061,881 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2019-12-31−329→ 662 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-12-31$5.82/sh−147→ 1,052,375 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-12-31$5.82/sh−329→ 1,044,165 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-12-31+329→ 1,044,494 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-11-30$7.79/sh−14,572→ 1,044,165 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-11-30$7.79/sh−6,544→ 1,052,193 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2019-11-30−14,572→ 29,144 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-11-30+14,572→ 1,058,737 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-09-30$3.18/sh−145→ 1,044,165 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2019-09-30−329→ 991 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-09-30+329→ 1,044,310 total
Tax Payment
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-08-31$3.80/sh−6,460→ 1,043,981 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2019-08-31−14,572→ 43,716 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-08-31+14,572→ 1,050,441 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Common Stock
2019-06-30+329→ 1,036,018 total
Exercise/Conversion
Aquestive Therapeutics, Inc.$AQST
Restricted Stock Units
2019-06-30−329→ 1,320 total

Companies

Aquestive Therapeutics, Inc.
Chief Innovation/Tech Officer
$AQST

Recent Filings

Address

C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE

WARREN, NJ, 07059

View on SEC.gov